European Urology Oncology

Slides:



Advertisements
Similar presentations
Josep M. Argilés, PhD, Nefertiti Campos, PhD, José M
Advertisements

Volume 63, Issue 5, Pages (May 2013)
European Urology Oncology
Volume 73, Issue 1, Pages (January 2018)
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.
Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S
European Urology Oncology
European Urology Oncology
Bladder Cancer: A Major Public Health Issue
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis  Mohamad B. Sonbol, Belal Firwana, Talal.
European Urology Oncology
European Urology Oncology
European Urology Oncology
Volume 64, Issue 3, Pages (September 2013)
European Urology Oncology
Counselling the Prostate Cancer Patient
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Volume 69, Issue 2, Pages (February 2016)
Stephen B. Williams, Ashish M
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Global Burden of Urologic Cancers, 1990–2013
Volume 68, Issue 6, Pages (December 2015)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
The Economic Costs of Overactive Bladder in Germany
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
European Urology Oncology
Role of Checkpoint Inhibition in Localized Bladder Cancer
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA  Nawar Hanna, Quoc-Dien Trinh,
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Volume 63, Issue 1, Pages (July 2015)
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.
European Urology Oncology
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
The Cost to Medicare of Bladder Cancer Care
Xueli Zhang, PhD, Yamin Liu, PhD, Hua Shao, MD, PhD, Xiao Zheng, PhD 
European Urology Oncology
European Urology Oncology
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy  Neal Patel, Eliza Cricco-Lizza,
Economic Burden of Bladder Cancer Across the European Union
European Urology Oncology
European Urology Oncology
European Urology Oncology
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
European Urology Oncology
Volume 43, Issue 1, Pages (January 2003)
European Urology Oncology
European Urology Oncology
European Urology Oncology
European Lung Cancer Conference (ELCC) 2016 Organisation
Volume 54, Issue 1, Pages (July 2008)
European Urology Oncology
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

European Urology Oncology Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer  Yingqi Wang, Andrew Chang, Wei Phin Tan, Joseph J. Fantony, Ajay Gopalakrishna, Gregory J. Barton, Paul E. Wischmeyer, Rajan T. Gupta, Brant A. Inman  European Urology Oncology  DOI: 10.1016/j.euo.2019.04.012 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 SMI, VATI, and SATI based on total physical activity, age, race, and gender. MET=metabolic equivalent; SATI=subcutaneous adipose tissue index; SMI=skeletal muscle index; VATI=visceral adipose tissue index. European Urology Oncology DOI: (10.1016/j.euo.2019.04.012) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 SMI, VATI, and SATI based on Healthy Eating Index, age, race, and gender. HEI=Healthy Eating Index; SATI=subcutaneous adipose tissue index; SMI=skeletal muscle index; VATI=visceral adipose tissue index. European Urology Oncology DOI: (10.1016/j.euo.2019.04.012) Copyright © 2019 European Association of Urology Terms and Conditions